Company Filing History:
1 out of 6,662 
1 out of 1,209 
1 out of 340 Years Active: 1995-2000
Title: Ralph Grassmann: Innovator in Gene Therapy
Introduction
Ralph Grassmann is a notable inventor based in Erlangen, Germany. He has made significant contributions to the field of gene therapy, particularly in the development of vectors for human T cells. With a total of 2 patents, Grassmann's work has paved the way for advancements in medical research and treatment.
Latest Patents
Grassmann's latest patents include innovative technologies that enhance the capabilities of human T cells. One of his patents describes selectable vectors for human T cells, specifically selectable Herpesvirus saimiri vectors. These vectors have a selection gene inserted into a junction region of the L- and H-DNA, allowing them to persistently infect human T cells without producing infectious virus particles. This feature makes them suitable for the expression of foreign genes in human T cells. Another significant patent is the H. saimiri-HTLV-X region vector, which can be utilized to establish continuous cell lines of difficult-to-grow cells, such as human T cells. This vector also has applications in obtaining certain cell products and in methods for screening new compounds.
Career Highlights
Throughout his career, Ralph Grassmann has worked with prominent organizations, including Hoechst Aktiengesellschaft and Dana-Farber Cancer Institute Inc. His work in these institutions has contributed to the advancement of cancer research and gene therapy.
Collaborations
Grassmann has collaborated with esteemed colleagues such as Bernhard W. Fleckenstein and William A. Haseltine. These partnerships have further enriched his research and innovations in the field.
Conclusion
Ralph Grassmann's contributions to gene therapy and his innovative patents have significantly impacted medical research. His work continues to inspire advancements in the treatment of various diseases.